Immunome Inc is a biopharmaceutical company engaged in the discovery and development of novel antibody-based drugs. The company's proprietary discovery platform identifies novel therapeutic antibodies and their targets by leveraging highly educated components of the immune system, memory B cells, from patients who have learned to fight off their disease. It is developing treatments for treating cancer and other infectious diseases.
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-05-01 | ||||||
| REV | |||||||
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.400 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| IMNM | Immunome | 0.7% | 324.1M |
Immunome Company Questions & Answers
Q
How do I buy Immunome (IMNM) stock?
A
You can purchase shares of Immunome (NASDAQ: IMNM) through any online brokerage.
Q
Who are Immunome's (IMNM) main competitors?
A
There are no as such competitors for Immunome.
Q
What is the target price for Immunome?
A
The latest price target for Immunome (NASDAQ: IMNM) was reported by Chardan Capital on 2020-10-27. The analyst firm set a price target for 18.00 expecting IMNM to fall to within 12 months (a possible -40.79% downside). 1 analyst firms have reported ratings in the last year.
Q
How much is Immunome (IMNM) stock ?
A
The stock price for Immunome (NASDAQ: IMNM) is $30.4 last updated Fri Apr 09 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
Q
When is the next Immunome (IMNM) dividend?
A
There are no upcoming dividends for Immunome.
Q
When is Immunome (NASDAQ:IMNM) reporting earnings?
A
Immunome’s Q1 earnings are confirmed from now on May 1, 2021.
Q
When is the upcoming split for IMNM?
A
There is no upcoming split for Immunome.